122 related articles for article (PubMed ID: 6465702)
21. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
[TBL] [Abstract][Full Text] [Related]
22. [Urinary oxalic acid excretion in chronic kidney failure and after kidney transplantation].
Mydlík M; Derzsiová K; Pribylincová V; Reznícek J
Vnitr Lek; 1996 Dec; 42(12):813-7. PubMed ID: 9072879
[TBL] [Abstract][Full Text] [Related]
23. Effect of hyperoxalaemia on factor VIII-related antigen in uremia.
Tomson CR; Channon SM; Ward MK; Hamilton PJ; Oxley A; Laker MF
Nephron; 1990; 54(3):276. PubMed ID: 2314548
[No Abstract] [Full Text] [Related]
24. Effect of vitamin C supplementation on renal oxalate deposits in five-sixths nephrectomized rats.
Ono K; Ono H; Ono T; Kikawa K; Oh Y
Nephron; 1989; 51(4):536-9. PubMed ID: 2739830
[TBL] [Abstract][Full Text] [Related]
25. Reduction of elevated plasma oxalic acid by pyridoxine therapy in patients on RDT.
Balcke P; Schmidt P; Zazgornik J; Kopsa H
Proc Eur Dial Transplant Assoc; 1983; 19():308-12. PubMed ID: 6878246
[TBL] [Abstract][Full Text] [Related]
26. Excessive myocardial calcinosis in a chronic hemodialyzed patient.
Zazgornik J; Balcke P; Rokitansky A; Schmidt P; Kopsa H; Minar E; Graninger W
Klin Wochenschr; 1987 Jan; 65(2):97-100. PubMed ID: 3560789
[TBL] [Abstract][Full Text] [Related]
27. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
[TBL] [Abstract][Full Text] [Related]
28. Secondary oxalosis in chronic renal insufficiency.
Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
N Engl J Med; 1980 Oct; 303(16):944. PubMed ID: 7412832
[No Abstract] [Full Text] [Related]
29. The oxalate level in ultrafiltrate fluid collected from a dialyzer is useful for estimating the plasma oxalate level in hemodialysis patients.
Ogi M; Abe R; Nishitani T; Wakabayashi M; Wakabayashi T
Clin Exp Nephrol; 2006 Jun; 10(2):118-23. PubMed ID: 16791397
[TBL] [Abstract][Full Text] [Related]
30. The effect of vitamin C intake on plasma oxalate in patients on regular haemodialysis.
Rolton HA; McConnell KM; Modi KS; Macdougall AI
Nephrol Dial Transplant; 1991; 6(6):440-3. PubMed ID: 1876286
[TBL] [Abstract][Full Text] [Related]
31. Ascorbic acid for anemia management in hemodialysis patients: a systematic review and meta-analysis.
Deved V; Poyah P; James MT; Tonelli M; Manns BJ; Walsh M; Hemmelgarn BR;
Am J Kidney Dis; 2009 Dec; 54(6):1089-97. PubMed ID: 19783342
[TBL] [Abstract][Full Text] [Related]
32. Plasma oxalate in chronic renal failure and normal subjects: methodological problems.
Dorhout Mees EJ; Boer P
Nephron; 1988; 48(3):256-7. PubMed ID: 3352859
[No Abstract] [Full Text] [Related]
33. [Kinetics of oxalate in hemodialysis].
Marangella M; Petrarulo M; Vitale C; Cosseddu D; Linari F
Minerva Urol Nefrol; 1991; 43(3):165-9. PubMed ID: 1817340
[TBL] [Abstract][Full Text] [Related]
34. Plasma profiles and dialysis kinetics of oxalate in patients receiving hemodialysis.
Marangella M; Petrarulo M; Mandolfo S; Vitale C; Cosseddu D; Linari F
Nephron; 1992; 60(1):74-80. PubMed ID: 1738418
[TBL] [Abstract][Full Text] [Related]
35. Effect of large intake of ascorbic acid on urinary and plasma oxalic acid levels.
Tsao CS; Salimi SL
Int J Vitam Nutr Res; 1984; 54(2-3):245-9. PubMed ID: 6500850
[TBL] [Abstract][Full Text] [Related]
36. Synovial fluid oxalate deposition complicating rheumatoid arthritis with amyloidosis and renal failure. Demonstration of intracellular oxalate crystals.
Schumacher HR; Reginato AJ; Pullman S
J Rheumatol; 1987 Apr; 14(2):361-6. PubMed ID: 3599006
[TBL] [Abstract][Full Text] [Related]
37. [Supply of ascorbic acid requirement in chronic kidney insufficiency and its modification by means of extracorporeal hemodialysis].
Kasper H; Muskat E; Mueller K
Klin Wochenschr; 1970 Aug; 48(15):946-7. PubMed ID: 5519313
[No Abstract] [Full Text] [Related]
38. Ascorbic acid administration and urinary oxalate.
Tsao CS
Ann Intern Med; 1984 Sep; 101(3):405-6. PubMed ID: 6465722
[No Abstract] [Full Text] [Related]
39. Ascorbic acid depletion during hemodialysis.
Sullivan JF; Eisenstein AB
JAMA; 1972 Jun; 220(13):1697-9. PubMed ID: 5067604
[No Abstract] [Full Text] [Related]
40. Elevation of the concentration of plasma oxalic acid in renal failure.
Zarembski PM; Hodgkinson A; Parsons FM
Nature; 1966 Oct; 212(5061):511-2. PubMed ID: 5970189
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
